BCMA / Luciferase - CHO Recombinant Cell Line
14392.50 €
In Stock
quantity
product details
Catalog number: 421 - 79724
Product Category: Business & Industrial > Science & Laboratory
Gentaur
Size: 2 vials
79715
CD22 / Luciferase - CHO Recombinant Cell Line
Recombinant clonal stable CHO cell line constitutively expressing full length human CD22 protein (Genbank #NM_001771) and the firefly luciferase. Surface expression of CD22 was confirmed by flow cytometry.
14392.50 €
79725
Firefly Luciferase - CHO Recombinant Cell Line
Recombinant CHO-K1 cells constitutively expressing the firefly luciferase reporter.
3022.43 €
79714
CD19 / Firefly Luciferase - CHO Recombinant Cell Line
Recombinant clonal stable CHO cell line constitutively expressing full length human CD19 protein (also known as B4 or CVID3, Genbank #NM_001770) and the firefly luciferase. Surface expression of CD19 was confirmed by flow cytometry.
16596.83 €
79557-M
CD22 CHO Recombinant Cell Line (Medium Expression)
Recombinant clonal stable CHO cell line constitutively expressing full length human CD22 protein (Genbank #NM_001771). Surface expression of CD22 was confirmed by flow cytometry. This clonal cell line was selected for medium level expression of CD22. A clone exhibiting higher levels of CD22 expression is also available (#79557-H). Please contact BPS Bioscience for additional information.
10983.75 €
79561-H
CD19 CHO Recombinant Cell Line (High Expression)
Recombinant clonal stable CHO cell line constitutively expressing full length human CD19 protein, also known as B4 or CVID3, (Genbank #NM_001770). Surface expression of CD19 was confirmed by flow cytometry. Each stable clonal cell line was selected for different levels of CD19 expression (High, Medium, Low) to mimic different stages of cancer target cells with various CD19 expression levels.
10983.75 €
79561-L
CD19 CHO Recombinant Cell Line (Low Expression)
Recombinant clonal stable CHO cell line constitutively expressing full length human CD19 protein, also known as B4 or CVID3, (Genbank #NM_001770). Surface expression of CD19 was confirmed by flow cytometry. Each stable clonal cell line was selected for different levels of CD19 expression (High, Medium, Low) to mimic different stages of cancer target cells with various CD19 expression levels.